Palbociclib in combination with letrozole as first-line treatment for advanced breast cancer: A Japanese phase II study-Reference-Cited by-同舟云学术

Palbociclib in combination with letrozole as first-line treatment for advanced breast cancer: A Japanese phase II study

Published:2018-02-22 Issue:3 Volume:109 Page:803-813
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Sci

Author:

Masuda Norikazu¹,Nishimura Reiki²,Takahashi Masato³,Inoue Kenichi⁴,Ohno Shinji⁵,Iwata Hiroji⁶,Mori Yuko⁷,Hashigaki Satoshi⁷,Muramatsu Yasuaki⁷,Nagasawa Takashi⁷,Umeyama Yoshiko⁷,Toi Masakazu⁸

Affiliation:

1. National Hospital Organization Osaka National Hospital; Osaka Japan

2. Kumamoto Shinto General Hospital; Kumamoto Japan

3. National Hospital Organization Hokkaido Cancer Center; Hokkaido Japan

4. Saitama Cancer Center; Saitama Japan

5. National Hospital Organization Kyushu Cancer Center; Fukuoka Japan

6. Aichi Cancer Center Hospital; Aichi Japan

7. Pfizer Japan Inc; Tokyo Japan

8. Kyoto University Graduate School of Medicine; Kyoto Japan

Funder

Pfizer

ClinicalTrials.gov

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/cas.13507/fullpdf

Reference27 articles.

1. An updated report on the trends in cancer incidence and mortality in Japan, 1958-2013;Katanoda;Jpn J Clin Oncol,2015

2. Characteristics and prognosis of Japanese female breast cancer patients: the BioBank Japan project;Nakamura;J Epidemiol,2017

3. Locally recurrent or metastatic breast cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up;Cardoso;Ann Oncol,2012

4. Advances in chemical pharmacotherapy to manage advanced breast cancer;Gombos;Expert Opin Pharmacother,2017

5. Global status of advanced/metastatic breast cancer: 2005-2015 decade report 2016 http://www.breastcancervision.com/sites/default/files/Global%20Status%20of%20mBC%20Report%20Summary_041416_Digital.pdf

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cholesterol de novo biosynthesis: a promising target to overcome the resistance to aromatase inhibitors in postmenopausal patients with estrogen receptor-positive breast cancer;Exploration of Medicine;2023-12-29

2. Overall survival in Japanese patients with ER+/HER2− advanced breast cancer treated with first-line palbociclib plus letrozole;Breast Cancer;2023-10-26

3. Exploring new pathways in endocrine-resistant breast cancer;Exploration of Targeted Anti-tumor Therapy;2022-06-20

4. Biomarkers for Cyclin-Dependent Kinase 4/6 Inhibitors in the Treatment of Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Advanced/Metastatic Breast Cancer: Translation to Clinical Practice;JCO Precision Oncology;2022-06

5. Palbociclib and letrozole in hormone-receptor positive advanced breast cancer: Predictive response and prognostic factors;Current Problems in Cancer;2022-06